These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 1282653
1. Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6'-dimycolate. Sazaki K, Yoshida I, Azuma M. Microbiol Immunol; 1992; 36(10):1061-75. PubMed ID: 1282653 [Abstract] [Full Text] [Related]
2. Correlation between augmented resistance to influenza virus infection and histological changes in lung of mice treated with trehalose-6,6'-dimycolate. Azuma M, Sazaki K, Nishikawa Y, Takahashi T, Shimoda A, Suzutani T, Yoshida I, Sakuma T, Nakaya K. J Biol Response Mod; 1988 Oct; 7(5):473-82. PubMed ID: 2460592 [Abstract] [Full Text] [Related]
3. Role of interferon in the augmented resistance of trehalose-6,6'-dimycolate-treated mice to influenza virus infection. Azuma M, Suzutani T, Sazaki K, Yoshida I, Sakuma T, Yoshida T. J Gen Virol; 1987 Mar; 68 ( Pt 3)():835-43. PubMed ID: 3493326 [Abstract] [Full Text] [Related]
4. Insufficient resistance of trehalose-6,6-dimycolate-treated T-cell receptor delta gene mutant (TCR delta-/-) mice against influenza virus infection. Hoq MM, Suzutani T, Nakaya K, Yoshida I, Ogasawara M, Takeda Y, Shibaki T, Itohara S, Yamamoto H, Azuma M. Microbiol Immunol; 1999 Mar; 43(5):491-3. PubMed ID: 10449256 [Abstract] [Full Text] [Related]
5. Role of gamma delta TCR+ lymphocytes in the augmented resistance of trehalose 6,6'-dimycolate-treated mice to influenza virus infection. Hoq MM, Suzutani T, Toyoda T, Horiike G, Yoshida I, Azuma M. J Gen Virol; 1997 Jul; 78 ( Pt 7)():1597-603. PubMed ID: 9225035 [Abstract] [Full Text] [Related]
6. Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Masihi KN, Lange W, Brehmer W, Ribi E. Int J Immunopharmacol; 1986 Jul; 8(3):339-45. PubMed ID: 3733302 [Abstract] [Full Text] [Related]
7. Pulmonary TCR γδ T cells induce the early inflammation of granuloma formation by a glycolipid trehalose 6,6'-dimycolate (TDM) isolated from Mycobacterium tuberculosis. Saitoh T, Yano I, Kumazawa Y, Takimoto H. Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):815-23. PubMed ID: 22963130 [Abstract] [Full Text] [Related]
8. CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate in mice. Guidry TV, Hunter RL, Actor JK. Microbiology (Reading); 2006 Dec; 152(Pt 12):3765-3775. PubMed ID: 17159227 [Abstract] [Full Text] [Related]
9. Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate. Masihi KN, Brehmer W, Azuma I, Lange W, Müller S. Infect Immun; 1984 Jan; 43(1):233-7. PubMed ID: 6317568 [Abstract] [Full Text] [Related]
10. Trehalose 6,6-Dimycolate from Mycobacterium tuberculosis Induces Hypercoagulation. Donnachie E, Fedotova EP, Hwang SA. Am J Pathol; 2016 May; 186(5):1221-33. PubMed ID: 26968340 [Abstract] [Full Text] [Related]
11. Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. Burger RA, Billingsley JL, Huffman JH, Bailey KW, Kim CU, Sidwell RW. Immunopharmacology; 2000 Apr; 47(1):45-52. PubMed ID: 10708809 [Abstract] [Full Text] [Related]
12. Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets. Masihi KN, Lange W, Rohde-Schulz B. Cancer Immunol Immunother; 1987 Apr; 24(1):19-24. PubMed ID: 3815418 [Abstract] [Full Text] [Related]
13. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice. Masihi KN, Brehmer W, Lange W, Ribi E, Schwartzman S. J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830 [Abstract] [Full Text] [Related]
14. A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Welsh KJ, Abbott AN, Hwang SA, Indrigo J, Armitige LY, Blackburn MR, Hunter RL, Actor JK. Microbiology (Reading); 2008 Jun; 154(Pt 6):1813-1824. PubMed ID: 18524936 [Abstract] [Full Text] [Related]
15. The generation of effector T cells in influenza A-infected, cyclosporine A-treated mice. Schiltknecht E, Ada GL. Cell Immunol; 1985 Oct 15; 95(2):340-8. PubMed ID: 3876162 [Abstract] [Full Text] [Related]
17. Evidence for a unique species-specific hypersensitive epitope in Mycobacterium tuberculosis derived cord factor. McMullen AM, Hwang SA, O'Shea K, Aliru ML, Actor JK. Tuberculosis (Edinb); 2013 Dec 15; 93 Suppl():S88-93. PubMed ID: 24388656 [Abstract] [Full Text] [Related]
18. In vivo effects of cyclosporine on influenza A virus-infected mice. Schiltknecht E, Ada GL. Cell Immunol; 1985 Mar 15; 91(1):227-39. PubMed ID: 2982505 [Abstract] [Full Text] [Related]
19. Development of TCR-gamma delta CD4-CD8+ alpha alpha but not TCR-alpha beta CD4-CD8+ alpha alpha i-IEL is resistant to cyclosporin A. Lin T, Matsuzaki G, Umesue M, Omoto K, Yoshida H, Harada M, Singaram C, Hiromatsu K, Nomoto K. J Immunol; 1995 Nov 01; 155(9):4224-30. PubMed ID: 7594578 [Abstract] [Full Text] [Related]
20. Influenza virus-specific T cells fail to reduce lung virus titres in cyclosporin-treated, infected mice. Schiltknecht E, Ada GL. Scand J Immunol; 1985 Jul 01; 22(1):99-103. PubMed ID: 3875147 [Abstract] [Full Text] [Related] Page: [Next] [New Search]